Filing Details

Accession Number:
0000856982-19-000123
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-09 19:15:03
Reporting Period:
2019-09-06
Accepted Time:
2019-09-09 19:15:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901534 P Fred Lampropoulos 1600 W Merit Parkway
South Jordan UT 84095
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Disposition 2019-09-06 150,000 $30.72 929,991 No 4 S Direct
Common Stock, No Par Value Disposition 2019-09-06 11,817 $30.41 1,269 No 4 S Indirect By spouse.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By spouse.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 90 Indirect By spouse as custodian for child.
Common Stock, No Par Value 94,815 Indirect By 401(k) Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $12.06 2015-10-04 2021-10-04 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $17.27 2016-02-13 2022-02-13 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $17.27 2016-02-13 2022-02-13 5,000 5,000 Indirect
Common Stock Non-qualified stock options (right to buy) $16.05 2017-01-28 2023-01-28 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $16.05 2017-01-28 2023-01-28 7,500 7,500 Indirect
Common Stock Non-qualified stock options (right to buy) $28.20 2018-04-14 2029-04-14 200,000 200,000 Direct
Common Stock Non-qualified stock options (right to buy) $28.20 2018-04-14 2029-04-14 10,000 10,000 Indirect
Common Stock Non-qualified stock options (right to buy) $44.80 2019-03-02 2025-03-02 38,002 38,002 Direct
Common Stock Non-qualified stock options (right to buy) $44.80 2019-03-02 2025-03-02 10,000 10,000 Indirect
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 159,151 159,151 Direct
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 10,000 10,000 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-10-04 50,000 50,000 Direct
2022-02-13 50,000 50,000 Direct
2022-02-13 5,000 5,000 Indirect
2023-01-28 50,000 50,000 Direct
2023-01-28 7,500 7,500 Indirect
2029-04-14 200,000 200,000 Direct
2029-04-14 10,000 10,000 Indirect
2025-03-02 38,002 38,002 Direct
2025-03-02 10,000 10,000 Indirect
2026-03-01 159,151 159,151 Direct
2026-03-01 10,000 10,000 Indirect
Footnotes
  1. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.55 to $31.13, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  2. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $30.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. Represents plan holdings as of 08/28/2019.
  4. Becomes exercisable in equal annual installments of 20% commencing 10/04/2015.
  5. Becomes exercisable in equal annual installments of 20% commencing 02/13/2016.
  6. Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
  7. Becomes exercisable in equal annual installments of 20% commencing 01/28/2017.
  8. Becomes exercisable in equal annual installments of 20% commencing 04/14/2018.
  9. Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.
  10. Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.